Diffusion-Weighted MRI of Breast Cancer: Improved Lesion Visibility and Image Quality Using Synthetic b-Values

Diffusion-weighted imaging (DWI) is an MRI technique with the potential to serve as an unenhanced breast cancer detection tool. Synthetic b-values produce images with high diffusion weighting to suppress residual background signal, while avoiding additional measurement times and reducing artifacts.

To compare acquired DWI images (at b = 850 s/mm² ) and different synthetic b-values (at b = 1000-2000 s/mm² ) in terms of lesion visibility, image quality, and tumor-to-tissue contrast in patients with malignant breast tumors.

Retrospective.

Fifty-three females with malignant breast lesions.

T₂ w, DWI EPI with STIR fat-suppression, and dynamic contrast-enhanced T₁ w at 3T.

From acquired images using b-values of 50 and 850 s/mm² , synthetic images were calculated at b = 1000, 1200, 1400, 1600, 1800, and 2000 s/mm² . Four readers independently rated image quality, lesion visibility, preferred b-value, as well as the lowest and highest b-value, over the range of b-values tested, to provide a diagnostic image.

Medians and mean ranks were calculated and compared using the Friedman test and Wilcoxon signed-rank test. Reproducibility was analyzed by intraclass correlation (ICC), Fleiss, and Cohen's κ.

Relative signal-to-noise and contrast-to-noise ratios decreased with increasing b-values, while the signal-intensity ratio between tumor and tissue increased significantly (P < 0.001). Intermediate b-values (1200-1800 s/mm² ) were rated best concerning image quality and lesion visibility; the preferred b-value mostly lay at 1200-1600 s/mm² . Lowest and highest acceptable b-values were 850 s/mm² and 2000 s/mm² . Interreader agreement was moderate to high concerning image quality (ICC: 0.50-0.67) and lesion visibility (0.70-0.93), but poor concerning preferred and acceptable b-values (κ = 0.032-0.446).

Synthetically increased b-values may be a way to improve tumor-to-tissue contrast, lesion visibility, and image quality of breast DWI, while avoiding the disadvantages of performing DWI at very high b-values.

3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:1754-1761.